The Effect of Intraoperative Hyperoxemia on Postoperative Delirium in Geriatric Patients
1 other identifier
observational
114
1 country
1
Brief Summary
Oxygen therapy is the most common treatment modality for patients with hypoxemia, but target values for normoxemia are not clearly defined. Therefore, iatrogenic hyperoxemia is a very common situation. Even though there are many side effects reported related to hyperoxemia and hyperoxemia is shown to be related to worse outcome than expected; clinicians still observe hyperoxemia frequently. Oxygen reserve index (ORi™) (Masimo Corp., Irvine, USA) can guide clinicians in detection of hyperoxia. ORi is a parameter which can evaluate partial pressure of oxygen (PaO2) rating from 0 to 1. There are growing evidences in ORi that it might be helpful to reduce hyperoxia in general anesthesia. Continuous ORi monitoring can be used for detecting and preventing hyperoxia. The ability to perform FiO2 titration with ORi may be an appropriate monitoring management to prevent the harmful effects of hyperoxia.In this study, in patients who underwent major abdominal surgery; It was aimed to investigate the effectiveness of ORi-guided FiO2 titration in preventing hyperoxia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2023
CompletedFirst Submitted
Initial submission to the registry
March 16, 2024
CompletedFirst Posted
Study publicly available on registry
March 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 5, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 7, 2024
CompletedJuly 9, 2024
March 1, 2024
9 months
March 16, 2024
July 7, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Correlation of FiO2 and ORi value
Correlation of FiO2 value and ORi value. FiO2 adjusted until ORi reaches to zero and %95\<oxygen saturation≤%98
Until the surgery is over
Correlation of ORi and Delirium
Correlation of ORİ and SpO2 values with delirium measured by CAM and CAM-ICU
Up to 48 hours
Secondary Outcomes (1)
Correlation of FiO2 and delirium
first 10 th minutes after entubation and every 10 minutes until surgery is over
Study Arms (2)
Control group
In the control group, observation will be conducted solely by another anesthesia doctor or assistant participating in the study, and the data will be recorded blindly without being reported to the anesthesia doctor responsible for the surgery. The oxygen therapy administered by the anesthesia doctor in charge and the FiO2 values will be recorded independently and blindly, based solely on the clinician's own assessment, rather than according to the information obtained from ORi. Subsequently, for two days following the surgery, evaluations will be conducted twice daily at the same hours for ward patients using CAM, and for ICU patients using CAM-ICU. If delirium is detected, delirium subtyping will be performed using the Richmond Agitation-Sedation Scale (RASS).
ORi+SpO2 group
In the SpO2+ORi group; It is aimed to maintain SpO2 between %95 and %98, and ORi at 0.00. Data will be recorded every 10 minutes. After extubation, patients will first be evaluated in the postoperative recovery room. Subsequently, for two days following the surgery, evaluations will be conducted twice daily at the same hours for ward patients using CAM, and for ICU patients using CAM-ICU. If delirium is detected, delirium subtyping will be performed using the Richmond Agitation-Sedation Scale (RASS).
Interventions
Fraction of inspired oxygen (FiO2) is titrated guided by oxygen saturation in that range; %95\<oxygen saturation
Titration of fraction of inspired oxygen (FiO2) guided by ORI and oxygen saturation FiO2 will be titrated by reducing 10% if Ori\>0.01 and oxygen saturation ≥ 98% until Ori is 0.00. FiO2 will not be changed if Ori is 0.00 and %95\<oxygen saturation≤%98 FiO2 will be increased by 10% if oxygen saturation \<95 or PaO2\<60 mmHg
Eligibility Criteria
Patients aged 65 and older. Geriatric patients
You may qualify if:
- Patients aged 65 and older
- Patients expected to have surgery lasting more than 2 hours
- Patients with ASA (American Society of Anesthesiologists) classification 1-2-3-4
- Patients planned to have at least 2 days of postoperative hospitalization
You may not qualify if:
- Patients with preoperative central nervous system disorders or dementia
- Patients with MMSE (Mini-Mental State Examination) scores of 23 or below
- Patients unable to communicate
- Emergency surgeries
- Patients who refuse to participate in the study
- Patients using high-dose vasopressors
- Patients with peripheral hypoperfusion
- Hemodynamically unstable patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aykut Saritaş
Izmir, 35640, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associated professor
Study Record Dates
First Submitted
March 16, 2024
First Posted
March 22, 2024
Study Start
October 1, 2023
Primary Completion
July 5, 2024
Study Completion
July 7, 2024
Last Updated
July 9, 2024
Record last verified: 2024-03